Saturday, December, 15, 2018 12:23:19

Category: Health

RoosterBio, TRT join hands to develop umbilical cord cell technology

Biotech firm Tissue Regeneration Therapeutics Inc. (TRT) and Maryland based RoosterBio Inc. (RBI) have recently announced a crucial strategic alliance for advancing their common goal. Apparently, their aim is to accelerate the development of the Cellular Therapy and Regenerative Medicine fields. This collaboration would allegedly …

Quest Diagnostics Inc. to procure BBPL’s laboratory services business

Quest Diagnostics Inc. (Quest), an American diagnostic information service provider, has reportedly announced that it has inked an agreement to acquire the laboratory services business unit belonging to Boyce and Bynum Pathology Laboratories (BBPL), a clinical & diagnostic laboratory service provider. Reports cite, the anatomic …

Eurofins to offer Synthego’s CRISPR technology to global clients

Eurofins Genomics, a global leader in bioanalytical testing has recently announced plans to collaborate with leading genome engineering products provider Synthego, to distribute sgRNA (synthetic single guide RNA) to the company’s global customer database across 44 countries. CRISPR technology is being accepted by clinical labs …

AstraZeneca inks deal with Sobi to sell the US rights for Synagis®

AstraZeneca, the pharmaceutical firm headquartered in Cambridge, has confirmed the sale of the U.S. rights to Synagis®, which is used for preventing respiratory tract infections, to specialty biopharmaceutical company Sobi AB. The multibillion-dollar deal would also involve nearly 130 workers being transferred to the Swedish …